Beta2-adrenergic agents in asthma
This project postulated a clinically significant anti-inflammatory action of beta<SUB>2</SUB>-agonists, in particular of salmeterol, a beta<SUB>2</SUB>-agonist with clinically proven bronchodilator properties. This hypothesis was investigated by two distinct approaches. First...
Main Author: | |
---|---|
Published: |
University of Aberdeen
1995
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.360346 |